Cytotoxic effect of jasmonate and methyl jasmonate on a canine macrophage tumor cell line

Author(s)

C. Hernandes ^[1] ; G.P. Cardozo ^[2] ; S.C. França ^[3] ; A.L. Fachin ^[4] ; M. Marins ^[5] ; M.V Lourenço ^[6]

Affiliation

^[1] Universidade de Ribeirão Preto - Brasil

^[2] Universidade de Ribeirão Preto - Brasil

^[3] Universidade de Ribeirão Preto - Brasil

^[4] Universidade de Ribeirão Preto - Brasil

^[5] Universidade de Ribeirão Preto - Brasil

^[6] Universidade de Ribeirão Preto - Brasil

• Document type: Journal article
• Source: Revista Brasileira de Plantas Medicinais; v. 14, n. 1, p. 122-124, 2012-00-00.

Abstract

Cancer is one of the leading causes of death in dogs, a fact that has boosted the investigation for new more specific antitumor drugs. This study evaluated the antitumor activity of jasmonates in the canine macrophage cell line DH82 (ATCC # CRL-10389) isolated from a case of malignant histiocytoma. The activities of methyl jasmonate and jasmonic acid were compared to that of doxorubicin by the MTT assay. Methyl jasmonate resulted in the highest inhibition of cell growth (82.2%), followed by doxorubicin (80.7%) and jasmonic acid (36.5%). More detailed studies regarding the action of jasmonates on animal health are necessary, but the present results indicate methyl jasmonate as an alternative to the development of drugs for the treatment of canine oncologies. (AU)

• FAPESP's process: 08/09815-9 - Jasmonates bioproduction by Botryosphaeria rhodina and citotoxic, antimicrobial and antimycotic activities in vitro bioassay.
• Grantee: Miriam Verginia Lourenço
• Support Opportunities: Regular Research Grants